ERBB2 and breast carcinoma: The activating phosphorylations of Akt at Ser473 and Thr308 were both induced by MEK inhibitor AZD6244 after four hours of treatment and reached the maximum after six hours in HER2‐positive SkBr3 breast cancer cell line (Fig. 1A).